What biopharma companies need to know about this evolving regulatory pathway.
Cori Gorman, PhD
Advertisement
Senior director, biopharmaceutical CMC and regulatory affairs, Cencora
Articles by Cori Gorman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
FDA Continues to Expand National Priority Voucher Program
4
Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?
5
